You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Actavis Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?

ACTAVIS has three hundred and twenty-five approved drugs.

There are twenty tentative approvals on ACTAVIS drugs.

Summary for Actavis

US Patents:	0
Tradenames:	229
Ingredients:	218
NDAs:	325
Patent Litigation for Actavis:	See patent lawsuits for Actavis
PTAB Cases with Actavis as petitioner:	See PTAB cases with Actavis as petitioner

Drugs and US Patents for Actavis

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Inc	DOXORUBICIN HYDROCHLORIDE	doxorubicin hydrochloride	INJECTABLE;INJECTION	203622-002	Jun 27, 2014	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Actavis Elizabeth	OXYMORPHONE HYDROCHLORIDE	oxymorphone hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079046-005	Jul 11, 2013		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Actavis Elizabeth	METHYLPHENIDATE	methylphenidate	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	210924-002	Jun 19, 2020		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Actavis Totowa	FINASTERIDE	finasteride	TABLET;ORAL	078371-001	Nov 5, 2013		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Actavis Elizabeth	INDAPAMIDE	indapamide	TABLET;ORAL	074722-001	Jun 17, 1996	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Actavis

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Actavis Labs Ut Inc	LOXITANE IM	loxapine hydrochloride	INJECTABLE;INJECTION	018039-001	Approved Prior to Jan 1, 1982	3,546,226	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ACTAVIS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.